Marina Biotech, Inc. Closes Previously Announced $5 Million Financing
06 janv. 2012 06h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Jan 6, 2012) - Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company, announced today that it has completed the...
Marina Biotech, Inc. to Present at Biotech Showcase 2012
03 janv. 2012 06h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Jan 3, 2012) - Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at...
Marina Biotech and Mirna Therapeutics Announce License Agreement for the Development of microRNA-Based Therapeutics
23 déc. 2011 06h45 HE
|
Marina Biotech, Inc.
BOTHELL, WA and AUSTIN, TX--(Marketwire - Dec 23, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics, Inc....
Marina Biotech Announces $5 Million Private Placement
23 déc. 2011 06h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Dec 23, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it has entered into a $5...
Marina Biotech to Remain Listed on The NASDAQ Global Market
30 nov. 2011 07h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Nov 30, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that the NASDAQ Listing...
Marina Biotech and Debiopharm SA Achieve Key Pre-Clinical Milestone in Bladder Cancer Program
29 nov. 2011 07h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Nov 29, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, today announced that the Marina/Debiopharm...
Marina Biotech Granted Patent Rights in China for Intranasal Insulin Delivery Formulations
17 nov. 2011 07h30 HE
|
Marina Biotech
BOTHELL, WA--(Marketwire - Nov 17, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported that the State Intellectual Property...
Marina Biotech, Inc. Announces Third Quarter 2011 Financial Results
10 nov. 2011 07h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Nov 10, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, today reported financial results for the...
Marina Biotech Demonstrates That Its Novel UsiRNA Oligonucleotide Abrogates Cytotoxicity Resulting From microRNA-Like Off-Target Activity
02 nov. 2011 07h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Nov 2, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported significant reduction of microRNA-like...
Marina Biotech, Inc. to Present at The 10th Annual BIO Investor Forum
19 oct. 2011 17h30 HE
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwire - Oct 19, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at The...